Related references
Note: Only part of the references are listed.Heterogeneity of response to immune checkpoint blockade in hypermutated experimental gliomas
Katrin Aslan et al.
NATURE COMMUNICATIONS (2020)
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
Florian Klemm et al.
CELL (2020)
Nuclear factor IX promotes glioblastoma development through transcriptional activation of Ezrin
Zhuohao Liu et al.
ONCOGENESIS (2020)
PD-L1 engagement on T cells promotes self-tolerance and suppression of neighboring macrophages and effector T cells in cancer
Brian Diskin et al.
NATURE IMMUNOLOGY (2020)
The Orphan Nuclear Receptor TLX Is a Receptor for Synthetic and Natural Retinoids
Kristine Griffett et al.
CELL CHEMICAL BIOLOGY (2020)
Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth
Jonathan B. Lamano et al.
CLINICAL CANCER RESEARCH (2019)
Challenges and potential of PD-1/PD-L1 checkpoint blockade immunotherapy for glioblastoma
Xin Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
Kurt A. Schalper et al.
NATURE MEDICINE (2019)
Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma
Timothy F. Cloughesy et al.
NATURE MEDICINE (2019)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
In Vitro and In Vivo Antitumor Activity of Cucurbitacin C, a Novel Natural Product From Cucumber
Dinglan Wu et al.
FRONTIERS IN PHARMACOLOGY (2019)
Expression of PD-1 by T Cells in Malignant Glioma Patients Reflects Exhaustion and Activation
Tom B. Davidson et al.
CLINICAL CANCER RESEARCH (2019)
Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer
Zhu Wang et al.
ENDOCRINE-RELATED CANCER (2018)
Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
Antonio Omuro et al.
NEURO-ONCOLOGY (2018)
Ten-year survival in glioblastoma. A systematic review
Tomasz Tykocki et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2018)
Current state of immunotherapy for glioblastoma
Michael Lim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription
Lin Jia et al.
ONCOGENE (2018)
Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes
Konrad Gabrusiewicz et al.
ONCOIMMUNOLOGY (2018)
The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma
Joseph DiDomenico et al.
ONCOIMMUNOLOGY (2018)
Classification of triple-negative breast cancers based on Immunogenomic profiling
Yin He et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
Sydney R. Gordon et al.
NATURE (2017)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Recurrent glioma clinical trial, CheckMate-143: the game is not over yet
Anna C. Filley et al.
ONCOTARGET (2017)
Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment
Soren Muller et al.
GENOME BIOLOGY (2017)
CD4+ T effector memory cell dysfunction is associated with the accumulation of granulocytic myeloid-derived suppressor cells in glioblastoma patients
Daniel Dubinski et al.
NEURO-ONCOLOGY (2016)
Nuclear receptor TLX inhibits TGF-β signaling in glioblastoma
Erik Johansson et al.
EXPERIMENTAL CELL RESEARCH (2016)
Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity
R. Dixon Dorand et al.
SCIENCE (2016)
Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion
Balint Otvos et al.
STEM CELLS (2016)
Downregulation of TLX induces TET3 expression and inhibits glioblastoma stem cell self-renewal and tumorigenesis
Qi Cui et al.
NATURE COMMUNICATIONS (2016)
Patterns of Immune Infiltration in Breast Cancer and Their Clinical Implications: A Gene-Expression-Based Retrospective Study
H. Raza Ali et al.
PLOS MEDICINE (2016)
PD-1 blockade enhances the vaccination-induced immune response in glioma
Joseph P. Antonios et al.
JCI INSIGHT (2016)
Orphan nuclear receptor TLX functions as a potent suppressor of oncogene-induced senescence in prostate cancer via its transcriptional co-regulation of the CDKN1A (p21WAF1/CIP1) and SIRT1 genes
Dinglan Wu et al.
JOURNAL OF PATHOLOGY (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Programmed death ligand 1 expression and tumor-infiltrating lymphocytes in glioblastoma
Anna Sophie Berghoff et al.
NEURO-ONCOLOGY (2015)
Targeting Self-Renewal in High-Grade Brain Tumors Leads to Loss of Brain Tumor Stem Cells and Prolonged Survival
Zhe Zhu et al.
CELL STEM CELL (2014)
Reciprocal Actions of microRNA-9 and TLX in the Proliferation and Differentiation of Retinal Progenitor Cells
Yamin Hu et al.
STEM CELLS AND DEVELOPMENT (2014)
Glioblastoma and Other Malignant Gliomas A Clinical Review
Antonio Omuro et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
The Nuclear Receptor TLX Is Required for Gliomagenesis within the Adult Neurogenic Niche
Yuhua Zou et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
miR-137 forms a regulatory loop with nuclear receptor TLX and LSD1 in neural stem cells
GuoQiang Sun et al.
NATURE COMMUNICATIONS (2011)
The nuclear receptor tailless induces long-term neural stem cell expansion and brain tumor initiation
Hai-Kun Liu et al.
GENES & DEVELOPMENT (2010)
The neural stem cell fate determinant TLX promotes tumorigenesis and genesis of cells resembling glioma stem cells
Hyo-Jung Park et al.
MOLECULES AND CELLS (2010)
Orphan nuclear receptor TLX activates Wnt/beta-catenin signalling to stimulate neural stem cell proliferation and self-renewal
Qiuhao Qu et al.
NATURE CELL BIOLOGY (2010)
Transrepressive function of TLX requires the histone demethylase LSD1
Atsushi Yokoyama et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
A role for adult TLX-positive neural stem cells in learning and behaviour
Chun-Li Zhang et al.
NATURE (2008)
Orphan nuclear receptor TLX recruits histone deacetylases to repress transcription and regulate neural stem cell proliferation
GuoQiang Sun et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Andrew T. Parsa et al.
NATURE MEDICINE (2007)
Expression and function of orphan nuclear receptor TLX in adult neural stem cells
YH Shi et al.
NATURE (2004)
Share Paper
